Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics

被引:52
作者
Bon, C. [1 ]
Toutain, P. L. [2 ]
Concordet, D. [3 ,4 ,5 ]
Gehring, R. [6 ]
Martin-Jimenez, T. [7 ]
Smith, J. [8 ]
Pelligand, L. [2 ]
Martinez, M. [9 ]
Whittem, T. [10 ]
Riviere, J. E. [6 ]
Mochel, J. P. [11 ]
机构
[1] Roche Innovat Ctr, Roche Pharmaceut Res & Early Dev, Basel, Switzerland
[2] Royal Vet Coll, Dept Vet Basic Sci, Hatfield, Herts, England
[3] INRA, Toxalim, Res Ctr Food Toxicol, Toulouse, France
[4] Univ Toulouse, ENVT, INP, Toxalim, Toulouse, France
[5] Ecole Natl Vet Toulouse, INRA, Lab Physiol & Therapeut, UMR 1331, Toulouse, France
[6] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Inst Computat Comparat Med ICCM, Manhattan, KS 66506 USA
[7] Univ Tennessee, Coll Vet Med, Dept Comparat Med, Knoxville, TN USA
[8] Iowa State Univ, Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA USA
[9] US FDA, Ctr Vet Med, Rockville, MD 20857 USA
[10] Univ Melbourne, Translat Res & Anim Clin Trials TRACTs Grp, Fac Vet & Agr Sci, Werribee, Vic, Australia
[11] Iowa State Univ, Biomed Sci, Coll Vet Med, Ames, IA 50011 USA
关键词
covariates; nonlinear mixed effects; population pharmacokinetics; sparse sampling; veterinary medicine; EFFICIENT PARAMETER-ESTIMATION; POPULATION PHARMACOKINETICS; BLOOD-PRESSURE; VETERINARY-MEDICINE; SAMPLING STRATEGIES; EXPERIMENTAL-DESIGN; FLUNIXIN MEGLUMINE; HANDLING DATA; DOGS; QUANTIFICATION;
D O I
10.1111/jvp.12473
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A common feature of human and veterinary pharmacokinetics is the importance of identifying and quantifying the key determinants of between-patient variability in drug disposition and effects. Some of these attributes are already well known to the field of human pharmacology such as bodyweight, age, or sex, while others are more specific to veterinary medicine, such as species, breed, and social behavior. Identification of these attributes has the potential to allow a better and more tailored use of therapeutic drugs both in companion and food-producing animals. Nonlinear mixed effects (NLME) have been purposely designed to characterize the sources of variability in drug disposition and response. The NLME approach can be used to explore the impact of population-associated variables on the relationship between drug administration, systemic exposure, and the levels of drug residues in tissues. The latter, while different from the method used by the US Food and Drug Administration for setting official withdrawal times (WT) can also be beneficial for estimating WT of approved animal drug products when used in an extralabel manner. Finally, NLME can also prove useful to optimize dosing schedules, or to analyze sparse data collected in situations where intensive blood collection is technically challenging, as in small animal species presenting limited blood volume such as poultry and fish.
引用
收藏
页码:171 / 183
页数:13
相关论文
共 81 条
  • [31] Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years
    Kontny, Nina E.
    Wuerthwein, Gudrun
    Joachim, Boos
    Boddy, Alan V.
    Krischke, Miriam
    Fuhr, Uwe
    Thompson, Patrick A.
    Joerger, Markus
    Schellens, Jan H. M.
    Hempel, Georg
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 749 - 763
  • [32] Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139
  • [33] Inter occasion variability in individual optimal design
    Kristoffersson, Anders N.
    Friberg, Lena E.
    Nyberg, Joakim
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 (06) : 735 - 750
  • [34] Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients
    Kuroda, T
    Kario, K
    Hoshide, S
    Hashimoto, T
    Nomura, Y
    Saito, Y
    Mito, H
    Shimada, K
    [J]. HYPERTENSION RESEARCH, 2004, 27 (01) : 15 - 20
  • [35] Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus)
    Leavens, Teresa L.
    Tell, Lisa A.
    Kissell, Lindsey W.
    Smith, Geoffrey W.
    Smith, David J.
    Wagner, Sarah A.
    Shelver, Weilin L.
    Wu, Huali
    Baynes, Ronald E.
    Riviere, Jim E.
    [J]. FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT, 2014, 31 (09): : 1506 - 1521
  • [36] Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses
    Lee, C. D.
    Maxwell, L. K.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2014, 37 (01) : 35 - 42
  • [37] Design and power of a population pharmacokinetic study
    Lee, PID
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (01) : 75 - 82
  • [38] Circadian change of cardiac autonomic function in correlation with intra-esophageal pH
    Lee, Yi-Chia
    Wang, Hsiu-Po
    Lin, Lian-Yu
    Chuang, Kai-Jen
    Chiu, Han-Mo
    Wu, Ming-Shiang
    Chen, Ming-Fong
    Lin, Jaw-Town
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (08) : 1302 - 1308
  • [39] Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest
    Lees, P
    Landoni, MF
    Giraudel, J
    Toutain, PL
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2004, 27 (06) : 479 - 490
  • [40] The role of pharmacokinetics in veterinary drug residues
    Lees, Peter
    Toutain, Pierre-Louis
    [J]. DRUG TESTING AND ANALYSIS, 2012, 4 : 34 - 39